Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Increase in Chronic Diseases
4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories
4.2.3 Increasing Demand for Point-of-Care Testing and Personalized Medicine
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Cumbersome Reimbursement Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Technique
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Hematology
5.1.4 Immuno Diagnostics
5.1.5 Other Techniques
5.2 Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Others
5.3 Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Autoimmune Disease
5.4.6 Nephrology
5.4.7 Other Applications
5.5 End Users
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals & Clinics
5.5.3 Other End Users


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 bioMerieux SA
6.1.5 Danaher Corporation
6.1.6 Epigenomics Inc.
6.1.7 F. Hoffmann-La Roche AG
6.1.8 Johnson & Johnson
6.1.9 Qiagen N.V.
6.1.10 Siemens Healthcare GmbH


7 MARKET OPPORTUNITIES AND FUTURE TRENDS